Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 29;25(1):2312318.
Epub 2024 Feb 13.

Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States

Karine Dubé  1   2 , Samuel O Ndukwe  1 , Ana Korolkova  1 , Lynda Dee  3   4 , Jeremy Sugarman  5 , John A Sauceda  6
Affiliations

Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States

Karine Dubé et al. HIV Res Clin Pract. .

Abstract

Background: There is limited systematic information available about the perspectives of participants enrolled in intensive combination HIV cure-related trials inclusive of an extended analytical treatment interruption (ATI).

Objective: To assess and understand experiences of people with HIV involved in a combination HIV cure-related trial with an extended ATI.

Methods: The trial included five interventions and was followed by an ATI lasting up to 52 wk. From 2022 - 2023, we conducted in-depth interviews with study participants following their extended ATIs. Interviews were audio-recorded, transcribed, and analyzed via conventional thematic analysis.

Results: We interviewed seven participants. The majority were male, White, and non-Hispanic, with a median age of 37 years. Trust in the research team, scientific altruism and hope of becoming a post-intervention controller were key motivators for joining the trial. Interviewees reported being satisfied with their decision to participate in the trial and the extended ATI. Most recounted feelings of worry related to viral rebound during the ATI. Participants reported both defeat and relief with ART restart. Four faced challenges with protecting partners from HIV during their ATI, such as trying to find out if their partner(s) were using pre-exposure prophylaxis.

Conclusions: Our findings demonstrate potential improvements for future ATI trial participant experiences, such as more robust resources for psychosocial support and partner protections. Dedicating greater effort to understanding participant ATI experiences can inform the design of future participant-centered HIV cure trial protocols.

Keywords: HIV cure research; analytical treatment interruptions; combination trials; participant experiences; people with HIV; socio-behavioral research.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Deeks SG, Archin N, Cannon P, et al. Research priorities for an HIV cure: International AIDS society global scientific strategy 2021. Nat Med 2021;27(12): 2085–2098. Available from: https://www.nature.com/articles/s41591-021-01590-5 - PubMed
    1. TAG. Research toward a cure trials 2023. Available from: http://www.treatmentactiongroup.org/cure/trials.
    1. Dubé K, Kanazawa J, Louella M, et al. Considerations for designing and implementing combination HIV cure trials: Findings from a qualitative in-depth interview study in the United States. AIDS Res Ther 2021;28(75):1–17. Available from: - PMC - PubMed
    1. Ananworanich J, Barré-Sinoussi F. Is it time to abandon single intervention cure trials? Lancet HIV 2015; 2(10):e410–e411. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26423646 - PubMed
    1. Hurst J, Hoffmann M, Pace M, et al. Immunological biomarkers predict HIV-1 viral rebound after treatment interruption. Nat Commun 2015;6(1):8495. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4633715&tool=p... - PMC - PubMed

Publication types